A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia

Abstract Background Combined inhibition of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) complexes may be an efficient treatment for acute leukemia. The primary objective of this phase I single center open label study was to determine the maximum tolerated dose (M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fabian Lang (Autor), Lydia Wunderle (Autor), Susanne Badura (Autor), Eberhard Schleyer (Autor), Monika Brüggemann (Autor), Hubert Serve (Autor), Susanne Schnittger (Autor), Nicola Gökbuget (Autor), Heike Pfeifer (Autor), Sebastian Wagner (Autor), Kevin Ashelford (Autor), Gesine Bug (Autor), Oliver G. Ottmann (Autor)
Format: Llibre
Publicat: BMC, 2020-09-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible